Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control

Radiotherapy and Oncology

Volumn 111, Issue 3, 2014, Pages 340-347

  Jeong, Jeho ^a   Setton, Jeremy S ^a   Lee, Nancy Y ^a   Oh, Jung Hun ^a   Deasy, Joseph O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Boost dose; FDG PET; Head and neck tumor; Inter institutional heterogeneity; Local control; Meta analysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; DRUG UPTAKE; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE ESCALATION; RADIOLOGICAL PARAMETERS; RADIOSENSITIVITY; RECURRENCE FREE SURVIVAL; TUMOR VOLUME; VERY ELDERLY; DOSE RESPONSE; HEAD AND NECK CANCER; HEAD AND NECK RADIOTHERAPY; OROPHARYNX CANCER; REVIEW;

BOOST DOSE; FDG-PET; HEAD AND NECK TUMOR; INTER-INSTITUTIONAL HETEROGENEITY; LOCAL CONTROL; META-ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 84905243762     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.03.018     Document Type: Article

References (53)

1. R.A. Gatenby, and R.J. Gillies Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4 2004 891 899 (Pubitemid 39472955)
2. A. van Baardwijk, B.G. Baumert, and G. Bosmans et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning Cancer Treat Rev 32 2006 245 260 (Pubitemid 44502002)
3. X. Zhong, J. Yu, and B. Zhang et al. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 73 2009 136 141
4. J. van Loon, J. Grutters, and R. Wanders et al. Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study Eur J Cancer 45 2009 588 595
5. M.P. MacManus, R.J. Hicks, J.P. Matthews, A. Wirth, D. Rischin, and D.L. Ball Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure Lung cancer 49 2005 95 108 (Pubitemid 40798098)
6. M. Agarwal, G. Brahmanday, S.K. Bajaj, K.P. Ravikrishnan, and C.Y.O. Wong Revisiting the prognostic value of preoperative 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC) Eur J Nucl Med Mol Imaging 2009 1 8
7. H. Vesselle, J.D. Freeman, and L. Wiens et al. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role Clin Cancer Res 13 2007 3255 3263 (Pubitemid 46944910)
8. W. Halfpenny, S.F. Hain, L. Biassoni, M.N. Maisey, J.A. Sherman, and M. McGurk FDG-PET. A possible prognostic factor in head and neck cancer Br J Cancer 86 2002 512 516 (Pubitemid 34185084)
9. T. Torizuka, Y. Tanizaki, and T. Kanno et al. Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer Am J Roentgenol 192 2009 W156 W160
10. M. Machtay, M. Natwa, and J. Andrel et al. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer Head Neck 31 2009 195 201
11. M. Kunkel, G.J. Förster, and T.E. Reichert et al. Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma Oral Oncol 39 2003 170 177 (Pubitemid 36050923)
12. P. Xie, J.B. Yue, Z. Fu, R. Feng, and J.M. Yu Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma Ann Oncol 21 2010 1078 1082
13. P. Castaldi, V. Rufini, and F. Bussu et al. Can "early" and "late" 18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? Radiother Oncol 103 2012 63 68
14. K. Herholz, U. Pietrzyk, and J. Voges et al. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study J Neurosurg 79 1993 853 858 (Pubitemid 23342449)
15. J.G. Rajendran, D.A. Mankoff, and F. O'Sullivan et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging Clin Cancer Res 10 2004 2245 2252 (Pubitemid 38445681)
16. 2- polarography in metastatic head and neck cancer Eur J Nucl Med Mol Imaging 33 2006 1426 1431 (Pubitemid 44885408)
17. V.K. Jain, V.K. Kalia, R. Sharma, V. Maharajan, and M. Menon Effects of 2-deoxy-d-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells Int J Radiat Oncol Biol Phys 11 1985 943 950 (Pubitemid 15096660)
18. I. Madani, W. Duthoy, and C. Derie et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 68 2007 126 135 (Pubitemid 46589860)
19. D.E. Soto, M.L. Kessler, M. Piert, and A. Eisbruch Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers Radiother Oncol 89 2008 13 18
20. H.J.W.L. Aerts, A.A.W. van Baardwijk, and S.F. Petit et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 2009 386 392
21. A. Abramyuk, S. Tokalov, and K. Zöphel et al. Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? Radiother Oncol 91 2009 399 404
22. B. Vanderstraeten, W. Duthoy, W.D. Gersem, W.D. Neve, and H. Thierens [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer Radiother Oncol 79 2006 249 258 (Pubitemid 44093755)
23. D. Berwouts, L.A. Olteanu, and F. Duprez et al. Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial Radiother Oncol 107 2013 310 316
24. R. Boellaard Standards for PET image acquisition and quantitative data analysis J Nucl Med 50 2009 11S 20S
25. E. Brun, E. Kjellén, and J. Tennvall et al. FDG pet studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma Head Neck 24 2002 127 135 (Pubitemid 34111509)
26. A.S. Allal, D.O. Slosman, T. Kebdani, M. Allaoua, W. Lehmann, and P. Dulguerov Prediction of outcome in head-and- neck cancer patients using the standardized uptake value of 2-[18f]fluoro-2-deoxy-d-glucose Int J Radiat Oncol Biol Phys 59 2004 1295 1300 (Pubitemid 38954050)
27. K. Ohnishi, Y. Shioyama, and M. Hatakenaka et al. Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma J Radiat Res 52 2011 522 530
28. H. Inokuchi, T. Kodaira, and H. Tachibana et al. Clinical usefulness of [18F] fluoro-2-deoxy-d-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection Int J Radiat Oncol Biol Phys 79 2011 747 755
29. S.C. Lin, C.Y. Liao, and C.H. Kao et al. Pretreatment maximal standardized uptake value of the primary tumor predicts outcome to radiotherapy in patients with pharyngeal cancer J Radiat Res 53 2012 462 468
30. R. Lim, A. Eaton, and N.Y. Lee et al. 18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma J Nucl Med 53 2012 1506 1513
31. N. Lee, S. Nehmeh, and H. Schöder et al. Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy Int J Radiat Oncol Biol Phys 75 2009 101 108
32. T.E. Schultheiss, C.G. Orton, and R.A. Peck Models in radiotherapy: volume effects Med Phys 10 1983 410 415 (Pubitemid 13025626)
33. S.M. Bentzen Dose-response relationships in radiotherapy M. Joiner, A. van der Kogel, Basic clinical radiobiology 4th ed. 2009 Hodder Arnold UK 56 67
34. P. Okunieff, D. Morgan, A. Niemierko, and H.D. Suit Radiation dose-response of human tumors Int J Radiat Oncol Biol Phys 32 1995 1227 1237
35. H.D. Thames, T.E. Schultheiss, J.H. Hendry, S.L. Tucker, B.M. Dubray, and W.A. Brock Can modest escalations of dose be detected as increased tumor control? Int J Radiat Oncol Biol Phys 22 1992 241 246
36. S.M. Bentzen Radiobiological considerations in the design of clinical trials Radiother Oncol 32 1994 1 11 (Pubitemid 24246758)
37. S.Y. Kim, J.L. Roh, and M.R. Kim et al. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx J Nucl Med 48 2007 752 757
38. K. Suzuki, T. Nishioka, and A. Homma et al. Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome? Jpn J Radiol 27 2009 237 242
39. P. Xie, J.B. Yue, and H.X. Zhao et al. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma J Cancer Res Clin Oncol 136 2010 883 889
40. M.K. Chung, H.S. Jeong, and S.G. Park et al. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer Clin Cancer Res 15 2009 5861 5868
41. C.H. Kao, S.C. Lin, and T.C. Hsieh et al. Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy Eur J Nucl Med Mol Imaging 39 2012 1297 1305
42. S.W. Lee, S.Y. Nam, and K.C. Im et al. Prediction of prognosis using standardized uptake value of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas Radiother Oncol 87 2008 211 216
43. J.L. Roh, K.H. Pae, and S.H. Choi et al. 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx Eur J Surg Oncol 33 2007 790 795 (Pubitemid 47029672)
44. E. Rusten, J. Rødal, O.S. Bruland, and E. Malinen Biologic targets identified from dynamic (18)FDG-PET and implications for image-guided therapy Acta Oncol 52 2013 1378 1383
45. N.Y. Lee, J.G. Mechalakos, and S. Nehmeh et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study Int J Radiat Oncol Biol Phys 70 2008 2 13 (Pubitemid 350251039)
46. C. Fakhry, and M.L. Gillison Clinical implications of human papillomavirus in head and neck cancers J Clin Oncol 24 2006 2606 2611 (Pubitemid 46622080)
47. B.S. Sørensen, M. Busk, and N. Olthof et al. Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells Radiother Oncol 108 2013 500 505
48. C. Schütze, R. Bergmann, and A. Yaromina et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice Radiother Oncol 83 2007 311 315 (Pubitemid 46915542)
49. K.M. Greven, D.W. Williams, and W.F. McGuirt et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer Head Neck 23 2001 942 946 (Pubitemid 32977536)
50. M.R. Vernon, M. Maheshwari, and C.J. Schultz et al. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma Int J Radiat Oncol Biol Phys 70 2008 678 684 (Pubitemid 351199732)
51. D. Zips, K. Zöphel, and N. Abolmaali et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer Radiother Oncol 105 2012 21 28
52. M.I. Bittner, N. Wiedenmann, and S. Bucher et al. Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy Radiother Oncol 108 2013 511 516
53. L.S. Mortensen, J. Johansen, and J. Kallehauge et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial Radiother Oncol 105 2012 14 20